Literature DB >> 2332500

Abnormal regulation of renal vitamin D catabolism by dietary phosphate in murine X-linked hypophosphatemic rickets.

H S Tenenhouse1, G Jones.   

Abstract

Hyp mice exhibit increased renal catabolism of vitamin D metabolites by the C-24 oxidation pathway (1988. J. Clin. Invest. 81:461-465). To examine the regulatory influence of dietary phosphate on the renal vitamin D catabolic pathway in Hyp mice, we measured C-24 oxidation of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) in renal mitochondria isolated from Hyp mice and normal littermates fed diets containing 0.03% (low-Pi), 1% (control-Pi), and 1.6% (high-Pi) phosphate. In normal mice the low-Pi diet led to a rise in serum 1,25(OH)2D (22.2 +/- 1.8 to 48.1 +/- 6.8 pg/ml, P less than 0.05) and no change in C-24 oxidation products (0.053 +/- 0.006 to 0.066 +/- 0.008 pmol/mg protein per min) when compared with the control diet. In Hyp mice the low-Pi diet elicited a fall in serum 1,25(OH)2D (21.9 +/- 1.2 to 8.0 +/- 0.2 pg/ml, P less than 0.05) and a dramatic increase in C-24 oxidation products (0.120 +/- 0.017 to 0.526 +/- 0.053 pmol/mg protein per min, P less than 0.05) when compared with the control diet. The high-Pi diet did not significantly alter serum levels of 1,25(OH)2D or C-24 oxidation products in normal mice. Hyp mice on the high-Pi diet experienced a rise in serum 1,25(OH)2D (21.9 +/- 1.2 to 40.4 +/- 7.3, P less than 0.05) and a fall in C-24 oxidation products (0.120 +/- 0.017 to 0.043 +/- 0.007 pmol/mg protein per min, P less than 0.05). The present results demonstrate that the defect in C-24 oxidation of 1,25(OH)2D3 in Hyp mice is exacerbated by phosphate depletion and corrected by phosphate supplementation. The data suggest that the disorder in vitamin D metabolism in the mutant strain is secondary to the perturbation in phosphate homeostasis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2332500      PMCID: PMC296591          DOI: 10.1172/JCI114590

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Increased renal catabolism of 1,25-dihydroxyvitamin D3 in murine X-linked hypophosphatemic rickets.

Authors:  H S Tenenhouse; A Yip; G Jones
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

3.  A new pathway of 25-hydroxyvitamin D3 metabolism.

Authors:  G Jones
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

4.  Abnormal relationship between serum phosphate concentration and renal 25-hydroxycholecalciferol-1-alpha-hydroxylase activity in X-linked hypophosphatemic mice.

Authors:  K Yamaoka; Y Seino; K Satomura; Y Tanaka; H Yabuuchi; M R Haussler
Journal:  Miner Electrolyte Metab       Date:  1986

5.  The role of abnormal vitamin D metabolism in X-linked hypophosphatemic rickets and osteomalacia.

Authors:  M K Drezner
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

6.  Investigation of the mechanism for abnormal renal 25-hydroxyvitamin D3-1-hydroxylase activity in the X-linked Hyp mouse.

Authors:  H S Tenenhouse
Journal:  Endocrinology       Date:  1984-08       Impact factor: 4.736

7.  Effect of the X-linked Hyp mutation and vitamin D status on induction of renal 25-hydroxyvitamin D3-24-hydroxylase.

Authors:  H S Tenenhouse; G Jones
Journal:  Endocrinology       Date:  1987-02       Impact factor: 4.736

8.  Side-chain oxidation of vitamin D3 in mouse kidney mitochondria: effect of the Hyp mutation and 1,25-dihydroxyvitamin D3 treatment.

Authors:  G Jones; A Yip; H S Tenenhause
Journal:  Biochem Cell Biol       Date:  1987-10       Impact factor: 3.626

9.  Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans.

Authors:  A A Portale; B P Halloran; M M Murphy; R C Morris
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

10.  Abnormal parathyroid hormone stimulation of 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the hypophosphatemic mouse. Evidence for a generalized defect of vitamin D metabolism.

Authors:  T Nesbitt; M K Drezner; B Lobaugh
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

View more
  11 in total

1.  Effects of Npt2 gene ablation and low-phosphate diet on renal Na(+)/phosphate cotransport and cotransporter gene expression.

Authors:  H M Hoag; J Martel; C Gauthier; H S Tenenhouse
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

2.  Phosphatonin washout in Hyp mice proximal tubules: evidence for posttranscriptional regulation.

Authors:  Michel Baum; Orson W Moe; Jianning Zhang; Vangipuram Dwarakanath; Raymond Quigley
Journal:  Am J Physiol Renal Physiol       Date:  2004-09-28

Review 3.  Role of prostaglandins in the pathogenesis of X-linked hypophosphatemia.

Authors:  Michel Baum; Ashu Syal; Raymond Quigley; Mouin Seikaly
Journal:  Pediatr Nephrol       Date:  2006-05-24       Impact factor: 3.714

4.  Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities.

Authors:  L Beck; A C Karaplis; N Amizuka; A S Hewson; H Ozawa; H S Tenenhouse
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

5.  Renal expression of Na+-phosphate cotransporter mRNA and protein: effect of the Gy mutation and low phosphate diet.

Authors:  L Beck; H S Tenenhouse; R A Meyer; M H Meyer; J Biber; H Murer
Journal:  Pflugers Arch       Date:  1996-04       Impact factor: 3.657

Review 6.  Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism.

Authors:  Jyothsna Gattineni; Michel Baum
Journal:  Pediatr Nephrol       Date:  2009-08-11       Impact factor: 3.714

7.  Fibroblast growth factor 23 regulates renal 1,25-dihydroxyvitamin D and phosphate metabolism via the MAP kinase signaling pathway in Hyp mice.

Authors:  Daniel Ranch; Martin Yh Zhang; Anthony A Portale; Farzana Perwad
Journal:  J Bone Miner Res       Date:  2011-08       Impact factor: 6.741

Review 8.  X-linked hypophosphataemia: a homologous phenotype in humans and mice with unusual organ-specific gene dosage.

Authors:  C R Scriver; H S Tenenhouse
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

9.  Correction of proximal tubule phosphate transport defect in Hyp mice in vivo and in vitro with indomethacin.

Authors:  Michel Baum; Samer Loleh; Neel Saini; Mouin Seikaly; Vangipuram Dwarakanath; Raymond Quigley
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-02       Impact factor: 11.205

Review 10.  Renal adaptation to phosphate deprivation: lessons from the X-linked Hyp mouse.

Authors:  H S Tenenhouse; J Martel
Journal:  Pediatr Nephrol       Date:  1993-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.